I Sens Inc
KOSDAQ:099190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
I Sens Inc
Cash Equivalents
I Sens Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Cash Equivalents
₩45B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Cash Equivalents
₩32.8B
|
CAGR 3-Years
445%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Cash Equivalents
₩35.1B
|
CAGR 3-Years
79%
|
CAGR 5-Years
77%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Cash Equivalents
₩10.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
Cash Equivalents
₩5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I Sens Inc
Glance View
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
See Also
What is I Sens Inc's Cash Equivalents?
Cash Equivalents
45B
KRW
Based on the financial report for Dec 31, 2025, I Sens Inc's Cash Equivalents amounts to 45B KRW.
What is I Sens Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
7%
Over the last year, the Cash Equivalents growth was -33%. The average annual Cash Equivalents growth rates for I Sens Inc have been -10% over the past three years , 8% over the past five years , and 7% over the past ten years .
